FDA Issues Warning Letters for Unapproved Omeprazole Drugs Marketed for Use in Horses
The U.S. Food and Drug Administration has issued nine warning letters to companies marketing unapproved animal drugs containing omeprazole. These products have not been reviewed by the FDA for safety and effectiveness. FDA testing also revealed that several of these products contained higher or lower levels of omeprazole than stated on their labels, ranging from as little as 36.3% to as much as 135% of the level claimed on the label.
This is subscriber-only content.
To continue reading, please log in
Share This Video: